| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-20 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.32 | 6e-19 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-17 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-17 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-16 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-16 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-15 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-15 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.29 | 9e-15 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-14 |